News & Presentations Filter by Category All 54 Company News 20 Media 11 Newsletter 6 Presentations & Webinars 18 Media, All Michelle Long 18/6/24 Media, All Michelle Long 18/6/24 Spark Plus desk note Read More Company News, All Michelle Long 5/6/24 Company News, All Michelle Long 5/6/24 Arovella completes manufacturing scale-up Read More Company News, All Michelle Long 23/5/24 Company News, All Michelle Long 23/5/24 EGM presentation and results Read More All, Newsletter Michelle Long 22/4/24 All, Newsletter Michelle Long 22/4/24 Arovella Newsletter April 2024 Read More Company News, All Bradley Cocks 18/4/24 Company News, All Bradley Cocks 18/4/24 Jumar Bioincubator opening, Melbourne | Home to Arovella's new office Read More Company News, All Michelle Long 9/4/24 Company News, All Michelle Long 9/4/24 Arovella presents ALA-101 data at AACR Read More All, Company News Michelle Long 3/4/24 All, Company News Michelle Long 3/4/24 Arovella expands Scientific Advisory Board with the appointment of Professor Gianpietro Dotti Read More Company News, All Bradley Cocks 27/3/24 Company News, All Bradley Cocks 27/3/24 Arovella to present at AACR Annual Meeting Read More Company News, All Bradley Cocks 26/3/24 Company News, All Bradley Cocks 26/3/24 Arovella funded to Phase 1 data: completes $12.5m placement Read More Presentations & Webinars, All Bradley Cocks 25/3/24 Presentations & Webinars, All Bradley Cocks 25/3/24 ASX Gems Conference 2024 Read More Presentations & Webinars, All Bradley Cocks 20/3/24 Presentations & Webinars, All Bradley Cocks 20/3/24 NWR Virtual Healthcare Conference Read More Presentations & Webinars, All Michelle Long 14/3/24 Presentations & Webinars, All Michelle Long 14/3/24 Spark Plus Singapore Healthcare Day Presentation Read More Media, All Michelle Long 20/2/24 Media, All Michelle Long 20/2/24 CEO Michael Baker’s interview with JustStocks Read More Media, All Michelle Long 30/1/24 Media, All Michelle Long 30/1/24 Arovella licenses novel CAR-iNKT cell armouring technology: Media coverage Read More Company News, Presentations & Webinars, All Michelle Long 30/1/24 Company News, Presentations & Webinars, All Michelle Long 30/1/24 Arovella enhances solid tumour pipeline by licensing novel CAR-iNKT cell armouring technology Read More Company News, All Michelle Long 2/1/24 Company News, All Michelle Long 2/1/24 Arovella completes key manufacturing step to progress ALA‐101 to clinic Read More Presentations & Webinars, All Michelle Long 11/12/23 Presentations & Webinars, All Michelle Long 11/12/23 CAR-iNKT cell platform data presented at ASH 2023 Read More Newsletter, All Michelle Long 4/12/23 Newsletter, All Michelle Long 4/12/23 Arovella Newsletter December 2023 Read More Presentations & Webinars, All Michelle Long 21/11/23 Presentations & Webinars, All Michelle Long 21/11/23 Monsoon Twilight Investor Briefing Presentation Read More Company News, All Michelle Long 20/11/23 Company News, All Michelle Long 20/11/23 Arovella receives R&D tax credit of $1.94m Read More Newer Posts Older Posts
Company News, All Michelle Long 5/6/24 Company News, All Michelle Long 5/6/24 Arovella completes manufacturing scale-up Read More
Company News, All Michelle Long 23/5/24 Company News, All Michelle Long 23/5/24 EGM presentation and results Read More
All, Newsletter Michelle Long 22/4/24 All, Newsletter Michelle Long 22/4/24 Arovella Newsletter April 2024 Read More
Company News, All Bradley Cocks 18/4/24 Company News, All Bradley Cocks 18/4/24 Jumar Bioincubator opening, Melbourne | Home to Arovella's new office Read More
Company News, All Michelle Long 9/4/24 Company News, All Michelle Long 9/4/24 Arovella presents ALA-101 data at AACR Read More
All, Company News Michelle Long 3/4/24 All, Company News Michelle Long 3/4/24 Arovella expands Scientific Advisory Board with the appointment of Professor Gianpietro Dotti Read More
Company News, All Bradley Cocks 27/3/24 Company News, All Bradley Cocks 27/3/24 Arovella to present at AACR Annual Meeting Read More
Company News, All Bradley Cocks 26/3/24 Company News, All Bradley Cocks 26/3/24 Arovella funded to Phase 1 data: completes $12.5m placement Read More
Presentations & Webinars, All Bradley Cocks 25/3/24 Presentations & Webinars, All Bradley Cocks 25/3/24 ASX Gems Conference 2024 Read More
Presentations & Webinars, All Bradley Cocks 20/3/24 Presentations & Webinars, All Bradley Cocks 20/3/24 NWR Virtual Healthcare Conference Read More
Presentations & Webinars, All Michelle Long 14/3/24 Presentations & Webinars, All Michelle Long 14/3/24 Spark Plus Singapore Healthcare Day Presentation Read More
Media, All Michelle Long 20/2/24 Media, All Michelle Long 20/2/24 CEO Michael Baker’s interview with JustStocks Read More
Media, All Michelle Long 30/1/24 Media, All Michelle Long 30/1/24 Arovella licenses novel CAR-iNKT cell armouring technology: Media coverage Read More
Company News, Presentations & Webinars, All Michelle Long 30/1/24 Company News, Presentations & Webinars, All Michelle Long 30/1/24 Arovella enhances solid tumour pipeline by licensing novel CAR-iNKT cell armouring technology Read More
Company News, All Michelle Long 2/1/24 Company News, All Michelle Long 2/1/24 Arovella completes key manufacturing step to progress ALA‐101 to clinic Read More
Presentations & Webinars, All Michelle Long 11/12/23 Presentations & Webinars, All Michelle Long 11/12/23 CAR-iNKT cell platform data presented at ASH 2023 Read More
Newsletter, All Michelle Long 4/12/23 Newsletter, All Michelle Long 4/12/23 Arovella Newsletter December 2023 Read More
Presentations & Webinars, All Michelle Long 21/11/23 Presentations & Webinars, All Michelle Long 21/11/23 Monsoon Twilight Investor Briefing Presentation Read More
Company News, All Michelle Long 20/11/23 Company News, All Michelle Long 20/11/23 Arovella receives R&D tax credit of $1.94m Read More
